Follow the latest coverage, related explainers and connected technology stories.
The U.S. Food and Drug Administration authorized the Claria System for marketing, a device that combines tissue morcellation and containment during certain laparoscopic uterine surgeries. The agency emphasizes that electromechanical morcellators should be used only in selected patients and with a compatible containment system because of the risk of spreading undetected uterine cancer.